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ABSTRACT
Oligodendrocytes form myelin sheaths around axons to
support rapid nerve conduction in the central nervous
system (CNS). Damage to myelin can cause severe CNS
disorders. In this study, we attempted to devise a protocol
for the induction of oligodendrocytes from human embry-
onic stem (ES) cells to treat demyelinated axons. Four
days after embryoid body formation, human ES cells were
differentiated into neural precursors through selection
and expansion procedures. Neural precursors were then
grown in the presence of epidermal growth factor and
then platelet-derived growth factor to generate oligoden-
drocyte precursor cells. After withdrawal of the growth
factors, the cells were treated with thyroid hormone to
induce differentiation into oligodendrocytes. This method
resulted in 81%–91% oligodendrocyte precursor cells
and 81% oligodendrocytes among total cells. The ability
of the oligodendrocyte precursors to myelinate axons has
been verified by coculturing with rat hippocampal neu-
rons, confirming their biological functionality. STEM
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INTRODUCTION
Embryonic stem (ES) cells derived from the inner cell mass of
blastocyst-stage embryos can proliferate indefinitely in vitro and
differentiate into any desired cell type under specific conditions
[1, 2]. These abilities make ES cells the promising source for
cell replacement therapies. Additionally, these cells are very
useful in the study of developmental biology and for drug/toxin
screening. Although mouse ES cells have been studied for more
than 2 decades [1, 2], human ES cells have only recently been
established [3]. The study of mouse ES cells has provided
insight into human ES cell research despite some differences in
properties between two types of cells.
Oligodendrocytes are myelinating cells in the central ner-
vous system (CNS) that form the myelin sheath of axons for
rapid nerve conduction [4]. In CNS disorders, such as stroke,
multiple sclerosis, and spinal cord injury, the demyelination of
axons contributes to functional deficits. Studies have demon-
strated that enhanced remyelination of damaged CNS axons by
cell transplantation can restore functions that were lost due to
demyelination [5–7]. However, this approach is limited by the
availability of a rich and effective source of oligodendrocytes
for myelin regeneration. ES cells can be a good cell source for
oligodendrocytes because they are pluripotent and are capable
of self-renewal.
Recently, Nistor et al. [8] were the first to report the deri-
vation of oligodendrocytes from human ES cells through yellow
sphere formation. Here, we introduce our newly developed
protocol by which oligodendrocyte precursors and mature oli-
godendrocytes can be efficiently induced.
MATERIALS AND METHODS
Human ES Cell Culture and Differentiation
into Oligodendrocytes
The undifferentiated human ES cell line, SNUhES1, was main-
tained as previously described [9]. For differentiation, human ES
cell colonies were liberated from their culture dishes by incubation
in 2 mg/ml collagenase type IV (Invitrogen, Carlsbad, CA, http://
www.invitrogen.com) for 40 minutes at 37°C. The detached human
ES cell colonies were transferred into bacterial culture dishes and
incubated in EB medium (ES cell culture medium without basic
fibroblast growth factor [bFGF]) to induce EB formation. After 4
days, the EBs were transferred onto matrigel (BD, Franklin Lakes,
NJ, http://www.bd.com)-coated culture dishes or coverslips. At-
tached EBs were cultured for 5 days in a ITSFn medium (Dulbec-
co’s modified Eagle’s medium [DMEM]/F12 supplemented with
1.0 mg/ml insulin, 0.55 mg/ml transferrin, 0.5 g selenium chloride,
and 5.0 g/ml Fibronectin) for the selection of neural progenitors
and were then continuously cultured for another 5 days in expansion
medium (DMEM/F12 including 20 ng/ml bFGF [Invitrogen] and
1 N2 supplements [R&D Systems, Minneapolis, http://www.
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rndsystems.com]) for the expansion of neural precursors [10, 11].
The neural rosettes and neural tube-like structures observed during
neural expansion culture [12] were mechanically isolated and re-
plated onto matrigel-coated culture dishes for oligodendroglial dif-
ferentiation in a medium (DMEM/F12 supplemented with N2
[R&D Systems], bFGF [Invitrogen; 10 ng/ml] and epidermal
growth factor [EGF] [Peprotech, Rocky Hill, NJ, http://www.
peprotech.com; 20 ng/ml] for 4 days, and then with N2, bFGF
[Invitrogen; 10 ng/ml] and platelet-derived growth factor [PDGF-
AA] [Peprotech; 10 ng/ml] for an additional 8 days). When the need
arose for further expansion of neural precursors, the neural rosettes
were cultured on bacterial culture dishes in expansion medium to
form neurosphere-like structures (spherical neural masses [SNMs])
that were expandable for a long period of time. Properly fragmented
pieces (40–80) from these spheres were plated onto matrigel-coated
culture dishes for differentiation of oligodendrocyte precursors, as
described above. Oligodendrocytes were then induced by growth
factor withdrawal and the addition of 3,35-triido-L-thyronine (T3)
(Sigma, St. Louis, http://www.sigmaaldrich.com; 30 ng/ml) (me-
dium composition: DMEM/F12 supplemented with N2 and T3) [13,
14]. Oligodendrocyte precursor cells and mature oligodendrocytes
were analyzed by immunocytochemistry, reverse transcription-
polymerase chain reaction (RT-PCR) and coculture with hippocam-
pal neurons from the brains of rat fetuses as described below. The
proportion of differentiated cells among the total number of cells
was also analyzed by random field counting and flow cytometry.
Immunostaining and Flow Cytometry Analysis
Immunostaining was performed with a slight modification of the
previous method [15]. Human ES cells were fixed with 4% form-
aldehyde (Electron Microscopy Sciences, Hatfield, PA, http://www.
emsdiasum.com) for 30 minutes, rinsed with phosphate-buffered
saline (PBS), and then incubated with blocking solution (PBS, 2%
bovine serum, 0.05% Triton X-100 in the case of intracellular
proteins) for 30 minutes. Cells were incubated overnight at 4°C with
primary antibodies diluted in PBS containing 2% bovine serum. The
dishes were washed with PBS and then incubated with fluorescent-
labeled secondary antibodies in PBS with 2% bovine serums for 30
minutes at room temperature. The dishes were rinsed for 3  10
minutes in PBS and mounted using Vectashield (Vector Laborato-
ries, Burlingame, CA, http://www.vectorlabs.com). The following
primary antibodies were used for immunocytochemistry: mouse
anti-human PDGF-R IgG (1:300), mouse anti-human A2B5 IgM
(1:500), mouse anti-human O4 IgM (1: 500) and mouse anti-human
O1 IgM (1:500, all from R&D Systems); rabbit anti-nestin IgG
(1:125), rabbit anti-NG2 IgG (1:200), rabbit anti-mouse myelin
basic protein (MBP) IgG (1:200) and mouse anti-human nuclei IgG
(1:125; all from Chemicon, Temecula, CA, http://www.chemicon-
.com). Other CNS cell types were identified using the following
antibodies: rabbit anti-bovine glial fibrillary acidic protein (GFAP)
IgG (1:500) and mouse anti--III-tubulin IgG (1:300), both from
Chemicon. The following secondary antibodies were then used to
localize bound primary antibodies: Alexa Fluor 488 donkey anti-
mouse and anti-rabbit IgG, Alexa Fluor 594-conjugated donkey
anti-mouse and anti-rabbit IgG (1:200, Molecular Probes, Eugene,
OR, http://probes.invitrogen.com).
For flow cytometry analysis, cells were dissociated by incuba-
tion for 5 minutes in 0.05% trypsin/0.1% EDTA (Invitrogen) at
37°C and then incubated in perforation solution (0.05% Triton
X-100) for 5 minutes in case of intracellular proteins. After the
treatment of the antibodies (without the treatment of primary anti-
bodies in control), cells were analyzed using FACScan and the Cell
Quest pro program (BD Bioscience, San Diego, http://www.
bdbiosciences.com).
RT-PCR
RT-PCR was performed as previously described [9]. The primer
sequences and the lengths of the amplified products are as follows
[16, 17]: glyceraldehyde-3-phosphate dehydrogenase (forward [F]:
5-AGCCACATCGCTCAGACACC-3 [20-mer]; reverse [R]: 5-
GTACTCAGCGGCCAGCATCG-3 [20-mer], 302 base pair [bp]),
PDGF-R (F: 5-GAAGCTGTCAACCTGCATGA-3 [20-mer]; R:
5-CGACTAGGCACGATTCCTTC-3 [20-mer], 167 bp), Nestin
(F: 5-CAGCTGGCGCACCTCAAGATG-3 [21-mer]; R: 5-
AGGGAAGTTGGGCTCAGGACTGG-3 [23-mer], 209 bp), pro-
teolipid protein (PLP) (F: 5-GGCGACTACAAGACCACCAT-3
[20-mer]; R: 5-GAAGTTGTGGACCTGGTGGA-3 [20-mer], 247
bp), MBP (F: 5-CTGGGCAGCTGTTAGAGTCC-3 [20-mer]; R:
5-TGGAGCAAAGGTTTGGTGTC-3 [20-mer], 275 bp), NG2 (F:
5-ACTGGCTAGGGGTGTCAATG-3 [20-mer]; R: 5-
TGAGTCGTCCTGGAACTCCT-3 [20-mer], 271 bp), GFAP (F:
5-TCATCGCTCAGGAGGTCCTT-3 [20-mer]; R: 5-CTGTT-
GCCAGAGATGGAGGTT-3 [21-mer], 383 bp), and Neurofila-
ment (F: 5-GAGCGCAAAGACTACCTGAAGA-3 [22-mer]; R:
5-CAGCGATTTCTATATCCAGAGCC-3 [23-mer], 209 bp).
In Vitro Myelination
The hippocampal neuron cultures we used were previously de-
scribed by Dotti et al. [18, 19]. Briefly, hippocampi were dissected
from the brains of 18-day-old rat fetuses, treated with 0.25% trypsin
for 15 minutes at 37°C, washed in Ca2,Mg2-free Hanks’ Bal-
anced Salt Solution (Gibco, Grand Island, NY, http://www.invitro-
gen.com), and dissociated by repeated pipetting. One  105 cells
were added to poly-D-lysine-coated 35-mm culture dishes in mini-
mal essential medium (MEM) (Gibco) containing 10% FBS
(Gibco). After 3–4 hours at 37°C, when the cells had attached to the
substrate, the media were replaced with MEM supplemented with
10 mM HEPES (Sigma; pH 7.3), pyruvate (Sigma; 0.01 mg/ml),
and N2. Then, oligodendrocyte precursor cells were added to the
neurons at a concentration of 2  104 cells per cm2 and cocultured
for 5 weeks. Electron microscopy and immunostaining were per-
formed as previously described [9, 15].
RESULTS
Differentiation of Human ES Cells into
Oligodendrocytes and Their Characterization
We used an EB-based method for in vitro differentiation of
oligodendrocytes and their progenitors from human ES cells.
Human ES cell colonies were detached by treatment with col-
lagenase type IV. After being transferred onto bacterial culture
dishes, detached human ES cell colonies were incubated in EB
medium for 4 days to form EBs. The EBs were attached on
culture dishes and cultured in the ITSFn medium for 5 days for
the selection of neural precursors. For the expansion of neural
precursors, the EBs were continuously cultured in the presence
of bFGF and N2 supplements for an additional 5 days. After
differentiation into neural precursors, structures with neural
rosettes (Fig. 1, arrows in 1A and 1B) were formed [20, 21].
These neural-specific structures that expressed neural markers
such as nestin (Fig. 2Aa) [11] were mechanically isolated and
attached on matrigel-coated dishes for differentiation into oli-
godendroglial progenitors. To further expand the neural precur-
sors, the neural rosettes were cultured in suspension with N2 and
bFGF supplements in bacterial dishes. The SNMs that resemble
so-called “neurospheres” were formed during the incubation of
these neural structures (Fig. 1C). The spheres were mechani-
cally dissected and expanded every 5–10 days, depending on
size. During this expansion, portions with non-neural morphol-
ogies were eliminated by mechanical cutting, which increased
the purity of the SNMs. Pure SNMs that were generated after
three or four passages could be expanded for a long period of
time, thus, continuously increasing the total mass. This means
that we could supply neural precursors indefinitely for any
experiment that requires mass production.
Attached neural precursors (from neural rosettes or
SNMs) on matrigel-coated culture dishes were incubated in
the presence of EGF for 4 days and, after adding PDGF, for
an additional 8 days. EGF stimulates the proliferation of
neural precursor cells in serum-free cultures [22], and PDGF
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regulates the timing of oligodendrocyte differentiation by
inducing the proliferation of early oligodendrocyte progeni-
tor cells for several divisions, thereby preventing premature
differentiation [23]. The combination of EGF and PDGF was
known to promote the proliferation of glial precursor cells
[10, 24 –26]. These conditions yielded an isomorphous pop-
ulation of round to bipolar cells characteristic of immature
cells (Fig. 1D, 1E). These cells expressed oligodendrocyte
precursor markers such as PDGF-R, A2B5, and NG2 (Fig.
2Ab–2Ad). PDGF-R, A2B5, and NG2 are membrane epitopes
typically expressed in oligodendrocyte precursor cells [27,
28]. We also used neurotrophin (NT)3 with PDGF or NT3
alone, but no differences in effect were found compared with
PDGF alone (data not shown).
For further differentiation into mature oligodendrocytes, the
growth factors (EGF, PDGF, and bFGF) were removed, and T3
was added. Thyroid hormone is required for oligodendrocyte
survival and activates the effector component of the timer in
oligodendrocyte precursor cells to initiate differentiation into
mature oligodendrocytes [29]. Upon growth factor withdrawal
and the addition of thyroid hormone, the cells differentiated into
mature oligodendrocytes. Ten days after growth factor with-
drawal, many of the cells showed a multipolar morphology
characteristic of immature oligodendrocytes (Fig. 1F, 1G). Pro-
longed growth factor withdrawal for more than 20 days pro-
moted further oligodendroglial differentiation (Fig. 1H, 1I), and
these cells expressed oligodendrocyte markers including oligo-
dendrocyte surface protein O4 (Fig. 2Ae), O1 (Fig. 2Af), and
MBP (Fig. 2Ag). O4 is an antigen on the surface of immature
oligodendrocytes to oligodendrocytes and O1 is a protein ex-
pressed on the surface of oligodendrocytes [30]. MBP is local-
ized to the major dense lines of myelin and confined to the
interior of oligodendrocytes [31]. After differentiation, only a
small percentage (less than 5%) of neurons (Fig. 2Ah) and
astrocytes (Fig. 2Ai; inset, positive control for astrocytes) were
detected.
The expression of several markers was also analyzed by
RT-PCR through the differentiation procedure (Fig. 2B). Nestin,
a marker of neural precursors, was detected in neural precursor
expansion culture (stage III). The reduction in nestin expression
was associated with the increased expression of oligodendrocyte
Figure 1. Differentiation of human embryonic stem (ES) cells into
oligodendrocytes. Phase contrast microscopic morphology of ES cell-
derived neural precursor cells (neural rosettes [A] and [B], spherical
neural masses [SNMs] [C]), oligodendrocyte precursor cells (D, E),
oligodendrocytes (F–I) following in vitro differentiation of human ES
cells. (A, B): Neural rosettes (arrows) were generated from attached
embryoid bodies. The neural rosettes were mechanically dissociated and
replated on matrigel-coated dishes for differentiation or cultured in
bacterial dishes to form SNMs (C) for further expansion of neural
precursors. (D, E): Cells show the typical bipolar morphology after10
days of differentiation from neural rosettes (D) or SNMs (E). (F, G):
Dendrites were spread in several directions. Ten days after basic fibro-
blast growth factor and platelet-derived growth factor withdrawal. (H,
I): Terminal differentiation evidenced by highly branched morphology
(arrows). Scale bar, 50 m. Figure 2. Expression of specific markers for neural precursors, oligo-
dendrocyte precursors, and oligodendrocytes. (A): Immunocytochemi-
cal staining of specific markers for neural precursors ([a], nestin),
oligodendrocyte precursors ([b], PDGF-R; [c], A2B5; [d], NG2), and
oligodendrocytes ([e], O4; [f], O1; [g], MBP). Anti--III-tubulin and
GFAP antibodies were used for the detection of neurons (h) and astro-
cytes ([i], inset; positive control-human normal astrocytes [Cambrex,
Walkersville, MD, http://www.cambrex.com]). 4,6-Diamidino-2-phe-
nylindole staining was also shown in blue in b, d, g, h, and i. Scale bar,
50 m. (B): Semiquantitative reverse transcription-polymerase chain
reaction analysis for various markers during in vitro differentiation of
human embryonic stem (ES) cells. The expression levels of each gene
were normalized to that of GAPDH. Stage I (undifferentiated ES cells);
stage II (EB); stage III (neural precursors); stage IV (oligodendrocyte
precursor cells); stage V (oligodendrocytes). Nestin (neural marker);
PDGF-R and NG2 (oligodendrocyte precursor markers); MBP and PLP
(oligodendrocyte markers); GFAP (astrocyte marker); Neurofilament
(neuronal marker). Abbreviations: GAPDH, glyceraldehyde-3-phos-
phate dehydrogenase; GFAP, glial fibrillary acidic protein; MBP, my-
elin basic protein; PDGF-R, platelet-derived growth factor-recpetor;
PLP, proteolipid protein.
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precursor markers following differentiation. The expression of
PDGF-R and NG2 (oligodendrocyte precursor markers) was
strongly upregulated during the induction of oligodendrocyte
precursors (stage IV) and was downregulated thereafter. After
final differentiation (stage V), the expression of oligodendro-
cyte-specific genes, such as MBP and PLP, was enhanced. The
marker of astrocytes, GFAP, and neuronal marker neurofilament
were not nearly detectable after differentiation, showing a good
correlation with immunostaining results. This result indicates
that the stage-specific marker genes are well expressed follow-
ing the differentiation procedure and there is enrichment of the
oligodendrocyte lineage relative to neurons or astrocytes.
After differentiation, we counted oligodendrocyte precursor
cells (stage IV) and oligodendrocytes (stage V) at the cellular
level. The majority of the cells were PDGF-R (82%) or A2B5-
positive (94%) at stage IV, and O1-positive (89%) at stage V.
Flow cytometry analysis (Fig. 3) revealed that most of the cells
expressed PDGF-R (81%), A2B5 (90.4%), NG2 (91.3%), and
O1 (81%), which is similar to the results of random field
counting. These results suggest that our in vitro protocol results
in efficient induction of oligodendrocytes and their progenitors
from human ES cells.
To determine whether these cells were biologically func-
tional in terms of myelination activity, the oligodendrocyte
precursor cells were cocultured with hippocampal neurons (Fig.
4). The hippocampal neurons were dissected from the brains of
18-day-old rat fetuses, treated with trypsin, and dissociated by
pipetting. After the neurons had attached on culture dishes,
oligodendrocyte precursors at a concentration of 2  104 per
cm2 were added and incubated for 5 weeks to induce myelina-
tion of the axons. The electron micrograph in Figure 4A–4C
shows a transverse section of a representative myelinated axon
by coculture. As shown in Figure 4B and 4C, the myelin sheets
compactly enclosed the axon of a neuron. Myelination of neu-
rons (red: arrow) were also confirmed by immunostaining using
anti-MBP (red) and -III-tubulin (green) antibodies (Fig. 4D).
MBP was hardly detected in cultures of hippocampal neurons
alone (Fig. 4E), indicating that myelination of neurons was due
to oligodendrocytes differentiated from human ES cells, but not
endogenous oligodendrocytes. This fact was confirmed using
antibody against human nuclei (Fig. 4F–4H). MBP-positive
oligodendrocytes (Fig. 4F, 4G, green) were human nuclei-pos-
itive (red), yielding yellow color (big arrows). In contrast,
hippocampal neurons (Fig. 4H, big arrow; Fig. 4F and 4G, small
arrows) were human nuclei-negative (blue). Figure 4J and 4K
showed that 25.8% of the hippocampal neurons in the cocul-
ture were myelinated MBP-positive cells, whereas1.6% of the
neurons were MBP-positive in the culture of hippocampal neu-
rons alone.
DISCUSSION
Oligodendrocytes produce myelin, which is wrapped around
axons in the CNS. The myelin sheath is lipid-rich and contains
several proteins such as MBP and PLP [31]. MBP and PLP are
important structural components of myelin that are involved in
the compaction of the myelin sheath. The myelination of axons
is essential for rapid conduction of nerve impulses. Thus, dam-
age to myelin can cause the loss of function that occurs in many
CNS disorders such as multiple sclerosis and spinal cord injury.
Oligodendrocyte-based cell therapy through remyelination may
be a good approach for inducing functional recovery in CNS
disorders [32–34] and ES cells are a good source for obtaining
oligodendrocytes and their progenitors [10, 35]. Several studies
have reported that mouse ES cells can differentiate into oligo-
Figure 3. Flow cytometry analysis of oligodendrocytes and their progenitors. Antibodies against PDGF-R (A), A2B5 (B), NG2 (C) (oligodendrocyte
precursor markers), and O1 (D) (oligodendrocyte marker) were used for the detection of oligodendrocytes and their progenitors. Stained cells were
analyzed using a FACScan. This analysis revealed that 81%–91% of total cells were oligodendrocyte progenitors and 81% of total cells were
oligodendrocytes. Abbreviation: PDGF-R, platelet-derived growth factor receptor.
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dendrocytes [10, 35, 36]. A previous study showed that when ES
cell-derived glial precursors were transplanted in a rat model of
a human myelin disease, the precursors efficiently myelinated
axons in brain and spinal cord [10]. Liu et al. [35] reported
achieving enriched cultures of oligodendrocytes through oligo-
sphere formation. When these cells were transplanted into the
spinal cord of shiverer mutant mice in which myelin was defi-
cient due to mutation in a MBP gene, the cells produced myelin
and myelinated host axons [34, 35].
More recently, Keirstead et al. [8, 34] introduced a method
for generating oligodendrocytes from human ES cells through
yellow sphere formation and showed their functionality after
transplantation into spinal cord injury model. They made
spheres by culturing detached human ES colonies on low bind-
ing plates and exposed the spheres to glial restriction media
(GRM) supplemented with growth factors with/without retinoic
acid throughout differentiation. Oligodendrocyte-lineage cells
within the cultures were enriched by a mechanical selection
procedure to select for yellow spheres based on preferential
adhesion.
In contrast, in our protocol, we dissected each stage (undif-
ferentiated ES cells-EB stage-neural precursor stage-oligoden-
drocyte precursor stage-mature oligodendrocyte) through differ-
entiation. Undifferentiated human ES cells were maintained on
an STO feeder layer and detached with the treatment of colla-
genase type IV. Detached human ES cell colonies were trans-
ferred onto bacterial culture dishes to induce EB formation. Four
days after EB formation, the EBs were transferred onto matri-
gel-coated culture dishes. We attempted to create neural rosettes
(neural precursors; Fig. 1A, 1B, arrows) from EBs through
neural selection (5 days in the ITSFn medium) and expansion
procedures (5 days in the presence of bFGF and N2 supple-
ments). These neural structures were then directly differentiated
into oligodendrocyte progenitor cells on matrigel-coated dishes
or used to create SNMs (Fig. 1C) in bacterial culture dishes for
further expansion of the neural precursors. One of the features of
our protocol is the creation of pure SNMs (pure neural precur-
sors) after undergoing mechanical selection upon the initial
expansion of the SNMs. After pure SNMs are created, they are
expandable for a long period of time and, thus, can provide
ample amounts of neural progenitors. These pure SNMs or
purely detached neural rosettes gave rise to oligodendrocytes
and their progenitors in high purity following differentiation.
Neural precursor cells (from neural rosettes or SNMs) are
treated with EGF for 4 days, followed by PDGF, for an addi-
tional 8 days to induce the formation of oligodendrocyte pre-
cursors. Using this method, our results yielded oligodendrocyte
progenitors as 81%–91% of the total cells (Fig. 3A–3C). These
precursors were bipolar (Fig. 1D, 1E) and positive for markers
such as PDGF-R, A2B5, and NG2 (Fig. 2Ab–2Ad). After with-
drawal of growth factors, bFGF, EGF, and PDGF, and the
addition of T3, the cells differentiated into mature oligodendro-
cytes for 14–21 days. With the passage of time, the cells were
morphologically changed into more mature oligodendrocyte
cells (Fig. 1F–1I), and the majority of the cells at final stage
expressed oligodendrocyte markers such as oligodendrocyte
surface proteins O4 (Fig. 2Ae) and O1 (Fig. 2Af), and MBP
(Fig. 2Ag). Neurons (Fig. 2Ah) or astrocytes (Fig. 2Ai) were
less than 5% of total cells. RT-PCR results showed that each
stage of differentiation expressed the representative markers
well (Fig. 2B), indicating that our in vitro protocol is sequen-
tially well dissected for the induction of neural precursors,
oligodendrocyte precursors, and mature oligodendrocytes, re-
spectively. When we analyzed the functionality of the differen-
tiated cells, we found that they formed multilayered compact
myelin sheaths in cocultures with hippocampal neurons from the
brains of rat fetuses (Fig. 4A–4C). Myelination of neurons was
Figure 4. Human embryonic stem (ES) cell-derived cells myelinate
axons in cocultures with fetus hippocampal neurons. Oligodendrocyte
precursor cells were cocultured with hippocampal neurons from the
brains of 18-day-old rat fetuses for 5 weeks. (A–C): The transmission
electron micrograph illustrates that the axons of hippocampal neurons
are surrounded by multilayered compact myelin sheets ([A], 70,000;
[B], 140,000; [C], 720,000). (D): Double immunostaining of MBP
(red) and -III-tubulin (green) after coculturing for 5 weeks. Myelina-
tion of axons (arrow, red) is shown. (E): Hippocampal neurons cultured
without human ES cell-derived oligodendrocytes were stained with
anti--III-tubulin (green) and anti-MBP antibodies (red), but MBP-
positive cells (red) as shown in (D), are hardly detectable. (F, G):
Double immunostaining of MBP (green) and human nuclei (red) after
coculture shows that the myelinating MBP-positive cells are human
cells (big arrows, yellow). Hippocampal neurons are shown as small
arrows. [H]: Costaining of -III-tubulin (red) and human nuclei (green)
after coculture. -III-tubulin-positive cells (hippocampal neurons) were
not labeled with anti-human nuclei antibody (big arrow). Human cells
are shown as small arrows (green). 4,6-Diamidino-2-phenylindole
staining (blue) is also shown in (D–H). Scale bar, 50 m. (I–K): Flow
cytometry analysis using antibodies against -III-tubulin and MBP. Of
total cells, 21% (25.8% of the neurons) were MBP-positive cells in
the coculture (J), whereas 1.2% of total cells (1.6% of the neurons)
were MBP-positive cells in the culture of hippocampal neurons alone
(K). Cells stained only with secondary antibodies were used as the
control (I). Abbreviation: MBP, myelin basic protein.
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also confirmed by immunostaining and flow cytometry after
cocultures with hippocampal neurons. Axons were stained
with anti-MBP antibody (Fig. 4D, red), and 25.8% of the
neurons were found to be MBP-positive (Fig. 4J). MBP-
positive cells were barely detectable in cultures of hippocam-
pus neurons alone (Fig. 4E, 4K). The MBP-positive oligo-
dendrocytes (green) were labeled with human-specific
antibody, anti-human nuclei antibody (red). (Fig. 4F, 4G,
merged yellow in big arrows). These results suggest that
myelination of hippocampal neurons is formed by oligoden-
drocytes differentiated from human ES cells, but not endog-
enous oligodendrocytes.
In conclusion, the in vitro protocol that we have developed
provides a high level of functional oligodendrocytes and their
progenitors from human ES cells. Our study may pave the way
for human ES cell-derived oligodendrocyte therapy in various
CNS myelin disorders.
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